Pharmaceutical composition comprising drospirenone and ethynylestradiol

A pharmaceutical composition that comprises drospirenone and ethynylestradiol with an improved dissolution rate. A method of preparation of a pharmaceutical formulation that comprises drospirenone and ethynylestradiol in order to improve its dissolution profile. Said formulation can be used to produ...

Full description

Saved in:
Bibliographic Details
Main Author SANDRONE CARLOS ARIEL,SAKSON JOSE MARIO,CAJARVILLE BASAISTEGUI MARIA D.,LARROSA POMI JOSE DANIEL
Format Patent
LanguageEnglish
Published 22.08.2007
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:A pharmaceutical composition that comprises drospirenone and ethynylestradiol with an improved dissolution rate. A method of preparation of a pharmaceutical formulation that comprises drospirenone and ethynylestradiol in order to improve its dissolution profile. Said formulation can be used to produce an anovulatory effect when administered correctly in humans.
Bibliography:Application Number: CN200580027105